Persistent preswitch clonotypic myeloma cells correlate with decreased survival: Evidence for isotype switching within the myeloma clone

Blood

Volumn 98, Issue 9, 2001, Pages 2791-2799

  Reiman, Tony ^a   Seeberger, Karen ^b   Taylor, Brian J ^b   Szczepek, Agnieszka J ^a   Hanson, John ^a   Mant, Michael J ^b   Coupland, Robert W ^a   Belch, Andrew R ^a   Pilarski, Linda M ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M;

ARTICLE; BONE MARROW; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; MYELOMA CELL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0035525742     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.9.2791     Document Type: Article

References (32)

1. Hallek M, Bergsagel PL, Anderson KC. Multiple myeloma: increasing evidence for a multistep transformation process. Blood. 1998;91:3-21.
2. Mellstedt H, Hammarstrom S, Holm G. Monoclonal lymphocytes in human plasma cell myeloma. Clin Exp Immunol. 1974;17:371-384.
3. Kubagawa H, Vogler LB, Capra JD, Conrad ME, Lawton AR, Cooper MD. Studies on the clonal origin of multiple myeloma. J Exp Med. 1979;150:792-807.
4. Bakkus MHC, Heirman C, Van Riet I, van Camp B, Thielmans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood. 1992;80:2326-2335.
5. + monoclonal B lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood. 1991;78:711-719.
6. Osterborg A, Steinitz M, Lewin N, et al. Establishment of idiotype bearing B-lymphocyte clones from a patient with monoclonal gammopathy. Blood. 1991;78:2642-2649.
7. Billadeau D, Ahmann G, Greipp P, Van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med. 1993;178:1023-1031.
8. Bakkus MHC, Van Riet I, Van Camp B, Thielemann K. Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. Br J Hematol. 1994;87:68-74.
9. Pilarski LM, Masellis S, Szczepek A, Mant MJ, Belch AR. Circulating clonotypic B cells in the biology of myeloma: speculations on the origin of multiple myeloma. Leuk Lymphoma. 1996;22:375-383.
10. Sahota S, Hamblin T, Oscier DG, Stevenson FK. Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myeloma. Leukemia. 1994;8:1285-1289.
11. Sahota SS, Leo R, Hamblin T, Stevenson FK. Ig VH gene mutation patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. Blood. 1996;87:746-755.
12. Sahota SS, Leo R, Hamblin T, Stevenson FK. Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells. Blood. 1997;89:219-226.
13. Vescio RA, Cao J, Hong CH, et al. Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity. J Immunol. 1995;155:2487-2497.
14. Szczepek AJ, Seeberger K, Wizniak J, Mant MJ, Belch AR, Pilarski LM. A high frequency of circulating B cells share clonotypic IgH VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single cell and in situ RT-PCR. Blood. 1998;92:2844-2855.
15. Nishida K, Tamura A, Nakazawa N, et al. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood. 1997;90:526-534.
16. Richelda R, Ronchetti D, Baldini L, et al. A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth factor receptor gene. Blood. 1997;90:4062-4070.
17. Finelli P, Fabris S, Zagano S, et al. Detection of t(4;14)(p16.4;q32) chromosomal translocations in multiple myeloma by double color fluorescent in situ hybridization. Blood. 1999;94:724-732.
18. Chesi M, Kuehl M, Bergsagel PL. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma. Ann Oncol. 2000;11:S131-S135.
19. Chesi M, Nardini E, Lim RS, Smith KD, Kuehl M, Bergsagel PL. The t(4;14)translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood. 1998;92:3025-3034.
20. Ho PJ, Brown RD, Pelka GJ, Basten A, Gibson J, Joshua DE. Illegitimate switch recombinations are known to be present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood. 2001;97:490-495.
21. Brown R, Luo XF, Gibson J, et al. Idiotypic olionucleotide probes to detect myeloma cells by mRNA in situ hybridization. Br J Haematol. 1998;90:113-118.
22. Brown RD, Luo X-F, Gibson J, et al. Longitudinal analysis of circulating myeloma cells detected by allele specific mRNA in situ hybridization. Am J Hematol. 1998;58:273-277.
23. + cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ rearrangements. Blood. 1997;89:1824-1833.
24. Corradini P, Voena C, Omede P, et al. Detection of circulating tumor cells in multiple myeloma by a PCR based method. Leukemia. 1993;7:1879-1882.
25. Palumbo A, Battagloi S, Astolfi M, Frieri R, Boccadoro M, Pileri A. Multiple independent Immunoglobulin class-switch recombinations occurring within the same clone in myeloma. Br J Hematol. 1992;82:676-680.
26. Pilarski LM, Hipperson G, Seeberger K, Pruski E, Coupland RW, Belch AR. Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice. Blood. 2000;95:1056-1065.
27. Aubin J, Davi F, Nuguyen-Salomon F, et al. Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia. 1995;9:471-479.
28. Billadeau D, Prosper F, Verfaillie CM, Weisdorf D, Van Ness B. Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement. Leukemia. 1997;11:1565-1570.
29. + B cells in peripheral blood of patients with multiple myeloma post high dose therapy and peripheral blood stem cell transplantation. Br J Haematol. 1999;106:545-552.
30. Guikema JEJ, Vellenga E, Veeneman JM, et al. Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation. Br J Haematol. 1999;104:748-754.
31. Kinashi T, Godal T, Noma Y, Ling NR, Taoita Y, Honjo T. Human neoplastic B cells express more than two isotypes of immunoglobulins without deletion of heavy chain constant region genes. Genes Dev. 1987;1:465-470.
32. Kunimoto DY, Sneller MC, Clafin L, Mushinski JF, Strober W. Molecular analysis of double isotype expression in IgA switching. J Immunol. 1993;150:1338-1347.